A B S T R A C T The influence of bile salts on the hepatic metabolism of sulfobromophthalein sodium (BSP) was studied in the perfused rat liver. During sodium taurocholate infusions, hepatic uptake of BSP from plasma was increased and appeared to be related to an enhanced transit of BSP from liver into bile. BSP-glutathione conjugation was not affected by the bile salt infusions, although bile salts inhibited the enzyme system in vitro.
INTRODUCTION
The removal of sulfobromophthalein sodium (BSP) from plasma and its excretion into bile involves hepatic uptake, storage, glutathione conjugation, and transport of the dye into the canaliculi (1) (2) (3) (4) (5) . As in the case of other organic anions, such as bilirubin, fluorescein, and land, Ohio. A 10%o dextrose solution, USP, used as a source of glucose, was obtained from Cutter Laboratories, Berkeley, Calif. Bromsulphalein (BSP), 50 mg/ml, was purchased from Hynson, Westcott & Dunning, Inc., Baltimore, Md. The sodium taurocholate preparation, obtained from Mann Research Laboratories, contained only two minor impurities as determined by thin-layer chromatography.
Rat liver perfusion. Sprague-Dawley rats weighing 300-400 g (Charles River Breeding Laboratory, Wilmington, Mass.) and maintained on Purina lab chow ad lib. served as liver and blood donors. The perfusion technique used was essentially that described by Miller, Bly, Watson, and Bale (21) . Two parts heparinized whole rat blood filtered through gauze were diluted with one part Krebs-Ringer bicarbonate buffer containing 5 g albumin and 100 mg glucose/100 ml, and adjusted to pH 7.45 with 1 N NaOH before use. The perfusate, which had a hematocrit of 16-22% (average 20%), was oxygenated with a mixture of 5% C02 and 95%o oxygen at a gas flow rate of 250 ml/min, and maintained at a constant temperature of 370C. In each experiment, 100 ml of oxygenated blood-buffer mixture was perfused through the portal vein via a glass cannula at a hydrostatic pressure of 14 cm. Bile was collected over 30-min intervals throughout the study in small tubes immersed in an ice bath protected against exposure to light. Hepatic blood flow, monitored each half hour, ranged from 22 to 32 ml/min. To avoid the use of livers with impaired secretory function attributable to anoxia, donor livers were rejected for perfusing if bleeding occurred before their removal, if the portal vein collapsed before cannulation, and if perfusion could not be initiated within 8 min after ligation of the portal vein. Also eliminated were experiments in which blood flow was not maintained within 20%7o of the rate attained after the 1st hr of the perfusion. It was found that the pH of the perfusate fell from 7.45 to 7.0 over a 5 hr period despite maintenance of the pC02 at 40 mm Hg. Since this occurred in both experimental and control perfusions, it was discounted as a factor in the results obtained.
Experimental design. The transport of BSP from plasma into liver and bile was studied in 21 perfusion experiments. An infusion of BSP at a constant rate of 378 ,ug/min was begun 30 min after the start of each perfusion and was maintained for 4.5 or 5 hr. A progressive rise in the concentration of the perfusate BSP was observed in all studies.
In the initial experiments, we studied BSP transport during a constant infusion of sodium taurocholate (30 ,moles/ hr). Five perfusions were performed and the results compared with five control studies. In five others, the infusion of taurocholate was begun either 3.5 or 4 hr after beginning the study. All of these perfusions were performed at 37'C.
In a second set of experiments, the temperature of the perfusate was altered to study BSP transport at varying rates of bile flow. Sodium taurocholate was infused as described above, to dissociate direct effects of bile salt on hepatic metabolism from its choleretic properties. BSP was infused at a rate of 392 ,ug/min. In three perfusions, the temperature was maintained at 40°C during the first 2 hr, diminished to room temperature (25°-30°C) from 2 to 4 hr, and again raised to 40°C for the final hour. In three other perfusions, hypothermia was maintained for the final hour but the bile salt infusion was doubled (60 /Amoles/hr) from 3.5 hr to completion of the 5 hr perfusion.
Measurements of bile volume and BSP content were made on each 30 min collection of bile in all studies. The total bile acid content of bile was estimated in each consecutive collection, and 1 ml of perfusate was analyzed for BSP at 1.5, 2.5, 3, and 5 hr.
The statistical significance of differences between groups was calculated by the paired t test (22) . BSP analysis. 10 ul of each half-hour collection of bile was thoroughly mixed with 10.0 ml saline to achieve concentrations of BSP that could be measured spectrophotometrically. Diluted bile samples and 0.5 ml aliquots of perfusate were analyzed for BSP by the method of Seligson, Marino, and Dodson (23), by use of a Zeiss PM QII spectrophotometer at 580 m/A. Neither albumin nor hemoglobin changed the molar extinction coefficient of BSP. Although dilution of dog bile has been found to reduce the recovery of BSP (7), quantitative recovery of BSP standards (25 mg/ml rat bile) was achieved in the present studies.
Liver weights. The liver weight used in all calculations was the weight of the untrimmed cannulated liver before infusion minus the weight of the cannula and excess tissue removed at the end of the experiment.
Total bile acid estimates. Total bile acids were determined quantitatively by Javitt and Emerman's modification (24) (26) and modified by Klaassen and Plaa (27) . Preliminary studies indicated that the enzyme activity in different lobes of the rat liver were comparable. The activity of the enzyme from the livers of 10 rats that were not perfused was also determined. (b) In a second experiment, sodium taurocholate was added to the pyrophosphate buffer contained in the enzyme reaction mixture to determine the effect of increasing amounts of bile salt on the in vitro BSP conjugating activity of normal rat liver. 1, 10, 25, 50, and 100 ,umoles of sodium taurocholate were added, and the assays were carried out in duplicate. No change in pH was observed in any of these reaction mixtures.
BSP metabolites. Separation of the metabolites of BSP in bile was performed on Merck precoated cellulose F plates, essentially as described by Whelan and Plaa (28) . For identification purposes, 1.0 /Al of a BSP standard (25 sg/dul) and 1.0 1l of the bile sample were applied at the origin with a 1.0 pAl pipette. For quantitative analysis of BSP and its conjugataes, 15 ul of bile were applied. A Wood's lamp was used to identify BSP and its metabolites (one large and three small fluorescent spots were observed in addition to the area containing the unconjugated BSP). The spot corresponding to unconjugated BSP was scraped from the plate into a glass vial containing 1 ml distilled water, while all the spots corresponding to the conjugates were transferred to a vial containing 5 ml of distilled water. The BSP was eluted by shaking in a Dubnoff incubator at 370C for 20 min.
The cellulose was then removed by centrifugation at 1200 rpm for 10 min, and quantitative analysis of 0.5 ml aliquots of the supernatant solution was performed as previously described. Total recoveries exceeded 90% in all instances.
The spots that were applied for identification purposes were sprayed with ninhydrin, and the color developed at 1000C for 2-3 min to confirm the presence of the BSP metabolite. Final confirmation that -the fluorescent spots were BSP was obtained by exposing the plate to ammonia fumes and observing the appearance of a dark purple color. Only the fluorescent spots developed color in the presence of ammonia. The per cent unconjugated BSP in a given sample was expressed as the ratio of unconjugated BSP to the total BSP content of the chromatographed sample.
Hepatic removal rate and hepatic content of BSP. Hepatic removal rate (R) of BSP from the perfusate was calculated from the equation: R = I ±plasma volume X Ap/At, where I = the infusion rate of BSP and Ap/At = the change in concentration of perfusate BSP/min. Plasma volume was determined from the hematocrit and perfusate volume. Hepatic content of BSP was determined by subtracting both the amount of BSP excreted into bile and that remaining in plasma from the total amount of BSP infused. Hepatic content was then expressed as a per cent of the total amount of infused BSP. Measurements of hepatic removal rate and hepatic content of BSP were made at 2.5 and 5 hr during the perfusion.
RESULTS
Effect of bile salts on bile flow, BSP Tm, and biliary concentration of BSP. The volume of bile produced during each half hour reached a maximum level within the first 2 hr in both control and taurocholate perfused livers ( Fig. 1 , lower graph). While the peak flow in controls was 1.06 ±0.17 Ad/min per g liver and then declined thereafter, a significantly higher peak flow rate of 1.50 ±0.12 Ad/min per g liver occurred during the sodium taurocholate infusion (P <0.001), and was maintained for the duration of the study.
Marked differences in the biliary concentration of bile acids were observed in the two studies (Fig. 1, upper  graph) . For the sake of comparison, the in vivo bile acid concentration was measured in bile collected for 15 min after cannulation of the common bile duct in 10 intact male rats. This is shown as the zero time value in the figure (32.5 ±5.4 /smoles/ml). The biliary con- (lower graph), total bile salt concentration in bile (upper graph) and the BSP transport maximum (Tm) (middle graph) in the perfused rat liver. The mean and standard deviation for each determination is represented for five control studies and five studies during sodium taurocholate infusion. Significant differences in bile flow were noted after the 1st half hour (P < 0.001) while differences in bile salt concentration in each hourly collection of bile were highly significant throughout the study (P < 0.001). Differences in the BSP Tm were significant by 2 hr (P < 0.05) and highly significant after 2.5 hr (P <0.001). The in vivo bile salt concentration in bile from normal intact rats was 32.5 ± 5.4 ,umoles/ml and is included for comparison. It is represented by the haif-shaded circle at zero time in the upper graph.
centration of bile acids in control perfused livers was only one-fifth of this value within the 1st hr of the perfusion, and remained at low levels thereafter. In contrast, during taurocholate infusion, the concentration remained at levels approximating in vivo biliary bile acid concentration. Furthermore, nearly all of the taurocholate infused was ultimately recovered in the bile, indicating that the perfused rat liver was capable of excreting the added bile salt. The effect of the bile salt infusion on the BSP transport maxima (Tm) is illustrated in the middle graph of Fig. 1 g liver during taurocholate infusion. This difference was statistically significant (P < 0.05). Moreover, the Tm declined progressively in the controls after 2 hr, but remained elevated during bile salt infusion. The difference in Tm was highly significant (P < 0.001) at 3 hr, and remained so for the last 2 hr of perfusion.
To further confirm that the decline in Tm noted in controls was related to low bile salt excretion and diminished bile flow, sodium taurocholate was infused in five additional experiments during the 4th hr of the perfusion. The results of a representative experiment are illustrated in Fig. 2 . Although the magnitude of the response differed in each of the studies, bile volume and the BSP Tm always rose above levels in the preceding half-hour bile collection. The concentration of BSP in bile during control and taurocholate infusion experiments is illustrated in Fig.  3 . During the period of peak bile flow (1.5-2 hr), the concentrations of BSP in bile were identical whether or not bile salts were infused. Thereafter, the concentration in controls fell slightly below that of the taurocholate-infused group, although the differences were not statistically significant except for the last hour of the perfusion.
The relationship between bile flow and the biliary excretion of bile salts and BSP. Since the previous studies suggested that bile salts regulated BSP transport by modifying the rate of bile flow, additional experiments were designed to test this hypothesis. Bile In the experiment illustrated in Fig. 5 , the temperature of the perfusate was maintained at 40'C for 2 hr and then was reduced to 250-30'C for 3 hr. As in the previous experiments, bile flow and BSP Tm fell during hypothermia. Moreover, enhancing bile salt excretion by doubling the infusion rate of bile acid during the 3rd hr of hypothermia did not increase either bile flow or BSP Tm.
BSP.conjugating activity. The effect of infusions of taurocholate or saline on the activity of the BSP-conjugating enzyme in the perfused rat liver is illustrated in Hepatic uptake and hepatic content of BSP. Although declining slightly during the course of all perfusions, the rate of hepatic BSP removal from plasma was enhanced above control values during the taurocholate infusion, both at 2.5 and 5 hr (Fig. 9) . However, despite the increased uptake, the fraction of infused BSP stored in the liver was lower than in control experiments (Fig. 10 ). Tm, and biliary excretion of bile tinued to parallel bile flow rather averaged 14.6 ±1.7 mg BSP/g though a slight decline in acti both the saline and taurocholat tivity from the perfused liver range for the entire course of eac addition of increasing amounts o assay progressively inhibited I gation- (Fig. 7) . The minimal cl required for inhibition was seve in excess of the presumed norn concentration of 10' mole/liter. BSP metabolites in bile. Dt sion, the proportion of unconju increased and ranged from 11.0 l hr and from 10 to 21% durinj Measurement of unconjugated 1 times in the control studies ran and from 2.4 to 8.6%. 3 4 The isolated perfused liver provides a unique model for the study of BSP metabolism, since it avoids probining hypothermia while lems encountered in the intact animal related to periphretion on bile flow, BSP eral uptake, enterohepatic circulation and urinary salts. BSP transport con-losses of dye. In addition, hormonal and neurogenic than bile salt excretion. effects are eliminated, particularly the endogenous relnAl-lease of secretin, which influences bile production and liver per 5 mm . Alsolute concentration (29 Moreover, the present studies show that the isolated g the 4th hr (Fig. 8) . perfused liver is capable of maintaining a level of BSP ISP in bile at respective transport comparable to that of the intact rat when the ged from only 2 to 4% biliary concentration of bile salt is maintained at physiologic levels. Thus, the BSP Tm, in our perfused livers, based on the body weight of donor rats, was found to be 0.8 ±0.09 mg/min per kg rat, whereas those reported for the intact rat by Combes (2) and Klaassen and Plaa (27) were 1.0 mg and 0.9 mg/min per kg rat, respectively.
The results of \the present study indicate that bile salts have a significant influence on the hepatic metabolism of BSP. The first effect observed after taurocholate infusion was an apparent increase in the hepatic uptake of the dye (Fig. 9) . Although little is known about the mechanism of hepatic uptake, BSP is tightly bound to albumin and must be removed in the process of transfer from plasma to hepatic binding proteins. Since Andrews and Richards have shown that bile salts have only a weak effect on the BSP-albumin bond (32), it is unlikely that the increase in uptake was attributable to dissociation of the BSP-albumin complex.
Furthermore, in preliminary studies we have been unable to demonstrate an increased hepatic uptake of BSP by rat liver slices in albumin and Krebs-Ringer bicarbonate buffer when incubated with bile salts (unpublished findings). These observations suggest that the enhanced uptake observed in our perfusion experiments was not due to a change in either the BSPalbumin bond or in the permeability or avidity of hepatic cells for BSP. The alternative hypothesis, that taurocholate inhibited the reflux of BSP from the hepatic cells into the perfusate, cannot be excluded with certainty. However, since the biliary excretion of BSP was increased by taurocholate (Fig. 1) , and the hepatic content of BSP in taurocholate-treated livers was less than that of control livers at any time after the onset of (Fig. 10) , it seems likely that the enhanced hepatic uptake of BSP from plasma was secondary to the more rapid transit of dye through the liver.
The major effect of sodium taurocholate on BSP metabolism was to enhance the BSP transport maximum. Similar observations in the intact animal have recently been reported by O'Maille, Richards, and Short (18) and Ritt and Combes in the dog (19) , and by Gronwell and Cornelius in the sheep (20) . Since bile salt increased the volume of bile secreted but did not enhance BSP concentration in our experiments, it would appear that the increase in BSP Tm was attributable to augmented bile flow. Thus, the peak concentartion of BSP in bile was identical in controls and in livers perfused with taurocholate (14.8 ±1.9 and 14.7 ±2.0 mg/ml, respectively), so that the increase in the transport of BSP was due entirely to the greater volume of bile flow during the taurocholate-induced choleresis. These results are similar to those of O'Maille et al., who noted no increase in the biliary concentartion of BSP when the Tm was enhanced 3-fold by taurocholate infusion in the dog (18) . Furthermore, in our studies, the decrease in bile flow that accompanied a reduction in bile salt excretion resulted in a progressive fall in the transport maximum. BSP concentration diminished only slightly so that the decline in transport was almost completely accounted for by the reduction in bile flow.
These data, as well as those of O'Maille et al. (18) , suggest that the concentration of BSP in canilicular bile has an upper limit which remains relatively constant over a wide range of bile production. If the concentra- tion of BSP within the canilicular bile is regulated by an energy-dependent liver cell-bile concentration gradient, as previously suggested by O'Maille et al. (18) , then the ability to concentrate BSP in bile may be the major limiting factor in the rate of BSP transport. If BSP concentration is limited, then changes in bile flow would independently effect proportional changes in the BSP transport maximum. The present data suggest therefore, that the BSP Tm is determined by two independent processes: a limited concentrating capacity for biliary BSP and the rate of bile production.
Although the results bf our experiments suggest that bile salts affect the BSP Tm by promoting bile flow rather than by enhancing the BSP concentrating capacity, it is conceivable that they enhance BSP transport by other means such as increasing membrane permeability, or stimulating a specific transport system. These possibilities seem unlikely, however, since the experiments illustrated in Figs. 4 and 5 indicated that BSP transport also paralleled temperature-regulated changes in bile flow rather than the concentration of biliary bile salts.
For example, BSP transport continued to be determined by the reduced rate of bile flow during hypothermia even though the biliary concentration of bile salts was increased by doubling the rate of taurocholate infusion (Fig. 5) . During these experiments, the biliary concentration of taurocholate approached the limit reported for the intact rat by Javitt and Harkavy (74 ±9 mmoles/liter) (33) but the infused bile salt was un- It might be argued, however, that the normal effect that bile salts exert on membranes to promote water or electrolyte secretion would be reduced during hypothermia, and consequently the observed changes in BSP Tm and bile flow might both be related to a bile salttemperature-dependent membrane effect. This seems very unlikely, since earlier work by Brauer, Leong, and Holloway (34) clearly demonstrated that bile production is temperature dependent in the perfused rat liver when bile salts are not infused into the perfusate. Since liver perfusion leads to a rapid depletion in the level of bile salt concentration (Fig. 1) , it is apparent that the temperature dependency of bile production does not primarily involve the function of bile salts and is more likely a direct effect of temperature on bile secretory metabolism. Furthermore, if hypothermia altered a temperature-dependent membrane-transport system, the biliary concentration of BSP or other transported solutes such as bile salts or bilirubin might be expected to decline. Extensive studies by Vanlerenberghe (35) during hypothermia in the perfused rat liver indicate that this does not occur and argue for two separate secretion mechanisms, one for the liquid phase and the other for dissolved substances. The results of these studies are consistant with our own conclusions that BSP transport is reduced during hypothermia because the volume of bile is diminished independently of the secretion of bile salts, thereby minimizing the importance of a bile salt-dependent membrane effect.
Because taurocholate increased unconjugated BSP excretion preferentially (Fig. 8) , the possibility must be considered that a carrier or transport system for this form of the dye was affected. However, it is more likely that the relative increase in unconjugated BSP in bile was attributable to a reduction in back diffusion as bile flow increased. Since unconjugated BSP is more lipid soluble than its conjugates, it might be anticipated that the former would back diffuse from the canaliculi to the hepatic cells more readily than the latter, and, hence, would be affected to a greater extent by rapid flow of bile that would reduce the period of its contact with the hepatocyte.
Since conjugation of BSP enhances its rate of excretion in bile (2, 17) bile salts might presumably increase BSP Tm by stimulating the BSP-glutathione conjugating system. However, in the present studies, BSP-glutathione conjugating activity remained stable throughout the 5-hr control perfusions, despite a decline in BSP Tm, and was not enhanced by taurocholate infusion, which increased BSP Tm. Indeed, in our in vitro experiments, high concentrations of taurocholate appeared to inhibit the conjugating system (Fig. 7) .
Thus, the results of the present study suggest that bile salts do not enhance the transport of BSP by altering membrane permeability, by stimulating a transport system, or by influencing BSP-glutathione conjugation.
Rather, it is clear that the rate of bile flow is an important determinant of the BSP Tm and that bile salts enhance the Tm when they are able to function as a choleretic.
Since bile salts are believed to be a major stimulus for bile production, it is not unreasonable to suggest that abnormalities in bile salt excretion may under some conditions result in changes in bile flow and account for abnormalities in BSP Tm. Further studies will be necessary to establish whether or not the biliary transport of other anions, such as bilirubin, may also have a limiting concentration in bile and be affected by changes in the rate of bile flow.
